0001493152-17-011156 Sample Contracts

ONCOCYTE CORPORATION AND [●], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [●], 20[●] ONCOCYTE CORPORATION FORM OF PREFERRED STOCK WARRANT AGREEMENT

Preferred Stock Warrant Agreement • October 2nd, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  October 2nd, 2017
• Company
  OncoCyte Corp
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ONCOCYTE CORPORATION, a California corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

ONCOCYTE CORPORATION AND [●], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [●], 20[●] ONCOCYTE CORPORATION FORM OF COMMON STOCK WARRANT AGREEMENT

Common Stock Warrant Agreement • October 2nd, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  October 2nd, 2017
• Company
  OncoCyte Corp
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ONCOCYTE CORPORATION, a California corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

ONCOCYTE CORPORATION AND [●], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [●], 20[●] ONCOCYTE CORPORATION FORM OF DEBT SECURITIES WARRANT AGREEMENT

Warrant Agreement • October 2nd, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Warrant Agreement
• Filed
  October 2nd, 2017
• Company
  OncoCyte Corp
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ONCOCYTE CORPORATION, a California corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).